Operating profit EBITDA: Solesence Inc (SLSN)

Graphic logo of Solesence (SLSN)

Solesence Inc proprietary mineral components create long-term B2B supply inertia, ensuring stable margins. Revenues are based on contracts with global beauty brands for the implementation of protective technologies. The company's EBITDA confirms financial stability, where the 1.05 metric serves as the target level. An active R&D pipeline and the Kleair platform ensure the release of new encapsulated formulas for premium cosmetics.

Profit before payment of interest, taxes and amortization: solesence.com (SLSN) for 11/23/2025 - 11/11/2026

Summary analytical data breakdowns for Solesence (SLSN)

- stock value and consensus price forecast:
Market Chart Solesence Beauty|SLSN - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Solesence Inc|SLSN - Enterprise Value
- book value of equity indicators:
Net Assets per Share Solesence Inc|SLSN - Company Book Value|Capitalization to Book Value Ratio solesence.com|SLSN - Aggregate Company Assets
- business debt structure and liquidity details:
Total Debt to Capital Coefficient Solesence Inc|SLSN - Long-Term Debt to Equity|Current Liabilities to Capital Solesence Beauty|SLSN - Company Debts|Debt to Book Capitalization Ratio Solesence Inc|SLSN - Company Long-Term Debts|Short-Term Debt Solesence Inc|Interim Coverage Ratio solesence.com
- company profitability and valuation multiples indicators:
SLSN - Net Profit|Expected Net Profit Solesence Inc|SLSN - Price to Earnings Ratio|Price to Future Earnings Ratio Solesence Beauty|SLSN - PEG Multiple|Enterprise Value to EBITDA Ratio Solesence Inc|SLSN - Operating profit EBITDA|Net earnings per one share for the last twelve months Solesence Inc|SLSN - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months solesence.com|SLSN - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Solesence Inc
Analysis of all company metrics:Solesence Inc (SLSN)
Signature product of solesence.com

To assess the long-term sustainability of Solesence Inc (SLSN), it is critical to monitor the daily cash flow from operating activities, which measures the real operational efficiency of the business per unit of time. By analyzing changes in EBITDA, an investor can see how global cosmetic brands' demand for patented mineral components converts into daily liquidity at US production sites.

Who Solesence Inc competes with

Operating income before deduction of amortization Krystal Biotech Corp. (KRYS)|APGE - Profit before payment of interest, taxes and amortization|ARQT - Operating profit EBITDA|VCEL: Operating profit EBITDA|ORKA - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Sanara MedTech, Inc.|Operating profit before amortization DBVT (DBV Technologies SA)|Profit before payment of interest, taxes and amortization Journey Medical (DERM)|Operating income before deduction of amortization fortebiorx.com|Profit before payment of interest, taxes and amortization Empro Group EMPG|Sol-Gel Technologies Ltd (SLGL) - Profit before interest, taxes and amortization|AXIL - Profit before payment of interest, taxes and amortization|MDCX: Profit before payment of interest, taxes and amortization|VRCA: Operating profit EBITDA|Profit before interest, taxes and amortization Hoth Therapeutics (HOTH)|Profit before payment of interest, taxes and amortization Biofrontera, Inc.|VYNE Therapeutics Inc (VYNE) - Operating income before deduction of amortization|Operating profit EBITDA SNOA|QNRX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Azitra, Inc. AZTR|DRMA: Operating profit before amortization|Elevai Labs - Operating profit EBITDA|Revance Therapeutics Inc. (RVNC) - Operating profit before deduction of amortization